US Stock MarketDetailed Quotes

PTC Therapeutics (PTCT)

Watchlist
  • 73.010
  • +2.590+3.68%
Close Apr 14 16:00 ET
  • 73.010
  • 0.0000.00%
Post 20:01 ET
6.04BMarket Cap9.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PTC Therapeutics (PTCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
114.51%1.73B
-22.75%164.68M
7.23%211.01M
-4.19%178.88M
459.73%1.18B
-13.97%806.78M
-30.58%213.17M
0.11%196.79M
-12.68%186.7M
-4.66%210.12M
Operating revenue
114.51%1.73B
-22.75%164.68M
7.23%211.01M
-4.19%178.88M
459.73%1.18B
-13.97%806.78M
-30.58%213.17M
0.11%196.79M
-12.68%186.7M
-4.66%210.12M
Cost of revenue
-18.09%47.01M
-57.32%6.95M
45.47%15.78M
-26.45%11.42M
-12.74%12.86M
-12.35%57.4M
-44.08%16.28M
14.27%10.85M
21.96%15.53M
4.21%14.74M
Gross profit
124.67%1.68B
-19.89%157.73M
5.00%195.23M
-2.17%167.46M
495.38%1.16B
-14.09%749.38M
-29.16%196.89M
-0.61%185.94M
-14.87%171.18M
-5.27%195.38M
Operating expense
-7.70%827.13M
12.50%239.35M
-19.41%191.74M
-1.09%202.31M
-19.59%193.73M
-26.65%896.13M
-22.58%212.76M
-21.68%237.9M
-36.42%204.53M
-25.05%240.93M
Selling and administrative expenses
15.36%347.14M
14.40%96.87M
14.42%84.05M
22.68%85.26M
10.49%80.96M
-9.51%300.91M
11.00%84.68M
-9.19%73.46M
-21.42%69.5M
-15.70%73.27M
Research and development costs
-14.82%455.25M
6.70%133.13M
-37.95%100.16M
-14.51%112.99M
-6.16%108.97M
-19.82%534.48M
2.82%124.77M
-1.71%161.41M
-28.89%132.17M
-40.48%116.13M
Depreciation amortization depletion
-59.26%24.74M
182.70%9.35M
148.16%7.53M
41.75%4.06M
-92.63%3.8M
-72.72%60.74M
-95.71%3.31M
-94.82%3.04M
-93.96%2.87M
30.74%51.53M
-Depreciation and amortization
-59.26%24.74M
182.70%9.35M
148.16%7.53M
41.75%4.06M
-92.63%3.8M
-72.72%60.74M
-95.71%3.31M
-94.82%3.04M
-93.96%2.87M
30.74%51.53M
Operating profit
683.66%856.51M
-414.30%-81.62M
106.71%3.49M
-4.50%-34.86M
2,228.29%969.5M
58.00%-146.75M
-608.69%-15.87M
55.46%-51.97M
72.35%-33.36M
60.46%-45.55M
Net non-operating interest income expense
8.84%-152.23M
-34.41%-55.19M
21.67%-32.59M
30.20%-30.36M
16.51%-34.09M
-29.27%-166.99M
7.26%-41.06M
-47.76%-41.61M
-47.85%-43.49M
-49.41%-40.83M
Non-operating interest expense
-8.84%152.23M
34.41%55.19M
-21.67%32.59M
-30.20%30.36M
-16.51%34.09M
29.27%166.99M
-7.26%41.06M
47.76%41.61M
47.85%43.49M
49.41%40.83M
Other net income (expense)
84.49%-7.66M
93.99%-2.27M
236.55%6.03M
34.32%-5.84M
-430.10%-5.58M
77.30%-49.38M
67.41%-37.77M
79.71%-4.42M
89.84%-8.89M
-77.62%1.69M
Special income (charges)
106.69%10.43M
107.01%10.28M
81.45%-472K
98.56%-99K
623.00%723K
31.55%-155.82M
-8.65%-146.52M
-69.60%-2.54M
92.28%-6.86M
104.17%100K
-Less：Restructuring and merger&acquisition
82.12%-800K
--0
--0
--0
-700.00%-800K
96.50%-4.48M
-276.85%-10.18M
-53.33%700K
103.96%5.1M
-104.17%-100K
-Less:Impairment of capital assets
-106.01%-9.63M
-106.56%-10.28M
-74.40%472K
-94.38%99K
--77K
-26.40%160.3M
--156.69M
--1.84M
-99.19%1.76M
--0
Other non- operating income (expenses)
-116.99%-18.09M
-111.54%-12.55M
447.33%6.5M
-183.31%-5.74M
-496.29%-6.31M
950.78%106.44M
473.52%108.75M
90.76%-1.87M
-236.92%-2.03M
-84.02%1.59M
Income before tax
291.84%696.62M
-46.87%-139.08M
76.45%-23.07M
17.12%-71.05M
1,197.84%929.83M
47.84%-363.12M
39.70%-94.7M
41.18%-97.99M
63.90%-85.73M
37.26%-84.7M
Income tax
7,840.34%13.98M
85.71%-4.12M
-549.84%-38.97M
-146.13%-6.2M
819.56%63.27M
100.25%176K
-2,188.56%-28.81M
125.77%8.66M
134.84%13.45M
73.34%6.88M
Net income
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
Net income continuous Operations
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
Minority interest income
Net income attributable to the parent company
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
Basic earnings per share
281.40%8.58
-96.47%-1.67
114.39%0.2
35.66%-0.83
1,024.17%11.09
43.49%-4.73
58.74%-0.85
21.02%-1.39
51.50%-1.29
36.17%-1.2
Diluted earnings per share
281.40%8.58
-96.47%-1.67
114.39%0.2
35.66%-0.83
936.67%10.04
43.49%-4.73
58.74%-0.85
21.02%-1.39
51.50%-1.29
36.17%-1.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 114.51%1.73B-22.75%164.68M7.23%211.01M-4.19%178.88M459.73%1.18B-13.97%806.78M-30.58%213.17M0.11%196.79M-12.68%186.7M-4.66%210.12M
Operating revenue 114.51%1.73B-22.75%164.68M7.23%211.01M-4.19%178.88M459.73%1.18B-13.97%806.78M-30.58%213.17M0.11%196.79M-12.68%186.7M-4.66%210.12M
Cost of revenue -18.09%47.01M-57.32%6.95M45.47%15.78M-26.45%11.42M-12.74%12.86M-12.35%57.4M-44.08%16.28M14.27%10.85M21.96%15.53M4.21%14.74M
Gross profit 124.67%1.68B-19.89%157.73M5.00%195.23M-2.17%167.46M495.38%1.16B-14.09%749.38M-29.16%196.89M-0.61%185.94M-14.87%171.18M-5.27%195.38M
Operating expense -7.70%827.13M12.50%239.35M-19.41%191.74M-1.09%202.31M-19.59%193.73M-26.65%896.13M-22.58%212.76M-21.68%237.9M-36.42%204.53M-25.05%240.93M
Selling and administrative expenses 15.36%347.14M14.40%96.87M14.42%84.05M22.68%85.26M10.49%80.96M-9.51%300.91M11.00%84.68M-9.19%73.46M-21.42%69.5M-15.70%73.27M
Research and development costs -14.82%455.25M6.70%133.13M-37.95%100.16M-14.51%112.99M-6.16%108.97M-19.82%534.48M2.82%124.77M-1.71%161.41M-28.89%132.17M-40.48%116.13M
Depreciation amortization depletion -59.26%24.74M182.70%9.35M148.16%7.53M41.75%4.06M-92.63%3.8M-72.72%60.74M-95.71%3.31M-94.82%3.04M-93.96%2.87M30.74%51.53M
-Depreciation and amortization -59.26%24.74M182.70%9.35M148.16%7.53M41.75%4.06M-92.63%3.8M-72.72%60.74M-95.71%3.31M-94.82%3.04M-93.96%2.87M30.74%51.53M
Operating profit 683.66%856.51M-414.30%-81.62M106.71%3.49M-4.50%-34.86M2,228.29%969.5M58.00%-146.75M-608.69%-15.87M55.46%-51.97M72.35%-33.36M60.46%-45.55M
Net non-operating interest income expense 8.84%-152.23M-34.41%-55.19M21.67%-32.59M30.20%-30.36M16.51%-34.09M-29.27%-166.99M7.26%-41.06M-47.76%-41.61M-47.85%-43.49M-49.41%-40.83M
Non-operating interest expense -8.84%152.23M34.41%55.19M-21.67%32.59M-30.20%30.36M-16.51%34.09M29.27%166.99M-7.26%41.06M47.76%41.61M47.85%43.49M49.41%40.83M
Other net income (expense) 84.49%-7.66M93.99%-2.27M236.55%6.03M34.32%-5.84M-430.10%-5.58M77.30%-49.38M67.41%-37.77M79.71%-4.42M89.84%-8.89M-77.62%1.69M
Special income (charges) 106.69%10.43M107.01%10.28M81.45%-472K98.56%-99K623.00%723K31.55%-155.82M-8.65%-146.52M-69.60%-2.54M92.28%-6.86M104.17%100K
-Less：Restructuring and merger&acquisition 82.12%-800K--0--0--0-700.00%-800K96.50%-4.48M-276.85%-10.18M-53.33%700K103.96%5.1M-104.17%-100K
-Less:Impairment of capital assets -106.01%-9.63M-106.56%-10.28M-74.40%472K-94.38%99K--77K-26.40%160.3M--156.69M--1.84M-99.19%1.76M--0
Other non- operating income (expenses) -116.99%-18.09M-111.54%-12.55M447.33%6.5M-183.31%-5.74M-496.29%-6.31M950.78%106.44M473.52%108.75M90.76%-1.87M-236.92%-2.03M-84.02%1.59M
Income before tax 291.84%696.62M-46.87%-139.08M76.45%-23.07M17.12%-71.05M1,197.84%929.83M47.84%-363.12M39.70%-94.7M41.18%-97.99M63.90%-85.73M37.26%-84.7M
Income tax 7,840.34%13.98M85.71%-4.12M-549.84%-38.97M-146.13%-6.2M819.56%63.27M100.25%176K-2,188.56%-28.81M125.77%8.66M134.84%13.45M73.34%6.88M
Net income 287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M34.10%-91.58M
Net income continuous Operations 287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M34.10%-91.58M
Minority interest income
Net income attributable to the parent company 287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M34.10%-91.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M34.10%-91.58M
Basic earnings per share 281.40%8.58-96.47%-1.67114.39%0.235.66%-0.831,024.17%11.0943.49%-4.7358.74%-0.8521.02%-1.3951.50%-1.2936.17%-1.2
Diluted earnings per share 281.40%8.58-96.47%-1.67114.39%0.235.66%-0.83936.67%10.0443.49%-4.7358.74%-0.8521.02%-1.3951.50%-1.2936.17%-1.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -